Brink's stock fell 0.96 percent. Analysts target USD 154.00

Published on 10/08/2026 at 07:34 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Brink's stock followed Q2 EPS of USD 2.13 versus USD 2.04 consensus on August 5, 2026. MarketBeat listed a Moderate Buy consensus and USD 154.00 average target.

BCO, US1096961040, Illustration mit AI erstellt.

The Brink's Company (ISIN US1096961040) had a USD 4.2 billion market capitalization on October 7, 2026, while Brink's stock was down 0.96 percent in NYSE trading. The share price was USD 102.51 at 1:05 p.m. ET, giving investors a dated market level alongside the company's latest earnings and acquisition milestones.

Second quarter beat expectations

MarketBeat reported that Brink's posted second-quarter EPS of USD 2.13 against a USD 2.04 consensus estimate after the August 5, 2026, release. Revenue reached USD 1.39 billion, up 7.0 percent from the comparable quarter, while third-quarter EPS guidance stood at USD 2.23-2.63.

The comparison matters because the earnings beat came with a revenue increase rather than a purely cost-driven result. The guidance range also puts the next operating checkpoint above the second-quarter EPS figure, although the two figures cover different reporting periods and should not be treated as a direct forecast comparison.

Acquisition keeps a regulatory hurdle

On September 30, 2026, GlobeNewswire published Brink's statement that it would propose selling the NoteMachine and TestLink UK businesses during the UK Competition and Markets Authority review of the NCR Atleos acquisition. The company said the transaction remained on track to close early in the first quarter of 2027 and retained its expectation of USD 200 million in annual run-rate cost synergies within three years of closing.

The regulatory remedy is the key counter-factor to the synergy case. Brink's identified approval requirements, divestiture terms, closing conditions and integration execution as risks in the same disclosure, so the USD 200 million figure remains a company expectation rather than a completed benefit.

Target stands above current price

MarketBeat listed a Moderate Buy consensus from four analysts, with two Buy ratings and two Hold ratings, and an average price target of USD 154.00. That target lies 50.2 percent above the USD 102.51 price on October 7, 2026, using the same USD currency.

The valuation gap gives the stock a clear market debate: the consensus target reflects confidence in earnings and the NCR Atleos combination, while the recent price remains below the USD 136.37 52-week high. The USD 91.05 52-week low and USD 4.2 billion market capitalization frame the trading range investors are weighing.

Brink's stock stays below its yearly high

Brink's stock was last at USD 102.51 on the NYSE on October 7, 2026, at 1:05 p.m. ET, down 0.96 percent from the USD 103.50 prior close. The same session showed a USD 101.72 low, a USD 103.57 high and volume of 130,020 shares.